おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Proof Diagnostics
company
About
Proof Diagnostics develops CRISPR‑based COVID‑19 molecular tests to help communities take control of their health.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $45M
- Industries
- Apps,Health Care,Mobile Apps,Product Management
- Founded date
- Jan 1, 2020
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Proof Diagnostics develops CRISPR‑based COVID‑19 molecular tests to help communities take control of their health.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$45M
Proof Diagnostics has raised a total of
$45M
in funding over 2 rounds. Their latest funding was raised on
Apr 7, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 7, 2022 | Series A | $45M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Proof Diagnostics is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
